Meeting
2022 ASCO Annual Meeting
Molecular characterization of long-term and short-term survivors of advanced pancreatic ductal adenocarcinoma.
Authors
Jesús Fuentes Antrás
Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada
Jesús Fuentes Antrás , Gun Ho Jang , James T. Topham , Amy Zhang , Erica S Tsang , Yifan Wang , Shawn Hutchinson , Anna Dodd , Julie Wilson , Faiyaz Notta , Sandra Fischer , Stephanie Ramotar , Shari Moura , Sevan Hakgor , Lillian L. Siu , George Zogopoulos , Steven Gallinger , Daniel Renouf , Grainne M. O'Kane , Jennifer J. Knox
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Biologic Correlates
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 4024)
DOI
10.1200/JCO.2022.40.16_suppl.4024
Abstract #
4024
Poster Bd #
12
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Evaluation of stage IV pancreatic adenocarcinomas based on mutational profiling of tumors.
First Author: Katherine E Poruk
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Genomic classification of clinically advanced pancreatic ductal adenocarcinoma (PDAC) based on methylthioadenosine phosphorylase (MTAP) genomic loss (MTAP loss).
First Author: Natalie Ngoi
Poster
2014 Gastrointestinal Cancers Symposium
Next-generation sequencing yields promising targets in advanced cholangiocarcinoma (CCA).
First Author: Rachna T. Shroff
Poster
2020 ASCO Virtual Scientific Program
Therapeutic vulnerabilities among KRAS G12C mutant (mut) advanced cancers based on co-alteration (co-alt) patterns.
First Author: Maliha Nusrat